Revenue Growth
RMD's revenue increased by 10.8% year-over-year, driven by strong sales performance across key markets.
RESMED INC is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: RMD reported strong financial performance in Q3 FY2026, with significant revenue growth and improved margins, driven by increased sales and effective cost management.
Drawn from management commentary in the Q1 2026 10-Q:
RMD's revenue increased by 10.8% year-over-year, driven by strong sales performance across key markets.
Gross margin improved to 62.2%, reflecting better cost management and higher operational efficiency.
R&D expenses rose by 12.3%, indicating a focus on innovation and product development.
Revenue
$1.43B
++10.81% YoY
EPS (Basic)
$2.74
++10.04% YoY
Gross Margin
62.2%
++2.91% YoY
Operating Income
$499.81M
++17.25% YoY
Add RMD to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.